Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05683821 · ClinicalTrials.gov registry record · Phase 4
BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 12,376
- Enrollment target
NCT05683821 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 12,376 participants.
The verdict
NCT05683821, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12,376 participants
- Enrollment target
Study Summary
The purpose of this research study is to see if offering adult primary care patients who smoke combustible cigarettes more frequent outreach, more choices about how they receive that outreach, and more smoking treatment options will increase the use of smoking treatments and help more people quit smoking, when compared against a standard outreach approach. Only patients at participating adult primary care clinics will be eligible for the study. Five clinic sites will be randomized to an enhanced outreach approach, while another 5 will be randomly assigned to standard smoking treatment outreach. Eligible patients at these clinics will be in this study for up to 18 months.
Interventions
- BEHAVIORAL Text message smoking treatment
- DRUG Nicotine replacement therapy sampling
- COMBINATION_PRODUCT Wisconsin Tobacco QuitLine Referral
- COMBINATION_PRODUCT Referral to Primary Care Provider
- COMBINATION_PRODUCT BREATHE 2 Cessation Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,376 participants |
| Start Date | 2023-07-24 |
| Est. Completion | 2025-05-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05683821
The ClinicalTrials.gov registry entry for NCT05683821 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12,376 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Text message smoking treatment is the first listed.
NCT05683821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05683821 about?
NCT05683821 is a clinical study titled "BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study". The purpose of this research study is to see if offering adult primary care patients who smoke combustible cigarettes more frequent outreach, more choices about how they receive that outreach, and more smoking treatment options will increase the use of smoking treatments and help more people quit sm...
What is the current status of trial NCT05683821?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12,376 participants. The study started on 2023-07-24. Estimated completion is 2025-05-07.
What interventions are being tested in trial NCT05683821?
The interventions under investigation include: Text message smoking treatment (BEHAVIORAL), Nicotine replacement therapy sampling (DRUG), Wisconsin Tobacco QuitLine Referral (COMBINATION_PRODUCT), Referral to Primary Care Provider (COMBINATION_PRODUCT), BREATHE 2 Cessation Study (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05683821?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.